Dyadic International (DYAI)
1.6300  +0.0100 (0.62%)

Dyadic International is a biotechnology company focused on developing and optimizing a proprietary platform for producing biologically-based products, including vaccines and therapeutics. The company leverages its advanced genetic engineering and expression technologies to create high-yield, cost-effective solutions for the pharmaceutical and biotech industries. Dyadic collaborates with partners to enhance drug development processes and aims to address significant health challenges through its innovative biomanufacturing capabilities. The organization is committed to advancing sustainable practices in life sciences and improving accessibility to critical medicines globally.

SummaryNewsPress ReleasesChartHistorical
Previous Close1.620
Open1.600
Bid1.500
Ask1.630
Day's Range1.501 - 1.630
52 Week Range0.9257 - 2.670
Volume34,183
Market Cap46.96M
PE Ratio (TTM)-10.87
EPS (TTM)-0.1
Dividend & YieldN/A (N/A)
1 Month Average Volume69,742

News & Press Releases

Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology
Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable Therapeutics
By Dyadic International, Inc. · Via GlobeNewswire · November 21, 2024
Earnings Scheduled For November 12, 2024benzinga.com
Via Benzinga · November 12, 2024
Exploring Dyadic International's Earnings Expectationsbenzinga.com
Via Benzinga · November 11, 2024
Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
JUPITER, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well as in non-pharmaceutical applications including food, nutrition, and wellness, today announced that it will report its financial results for the third quarter 2024 and host a corporate update conference call on Tuesday, November 12, 2024.
By Dyadic International, Inc. · Via GlobeNewswire · November 4, 2024
Dyadic Expands Global Presence with Participation in Key Industry Events
JUPITER, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the large-scale, efficient manufacturing of proteins for human and animal vaccines, therapeutics, and non-pharmaceutical applications, including food, nutrition, and wellness, today announced its participation in several prominent industry events worldwide.
By Dyadic International, Inc. · Via GlobeNewswire · October 9, 2024
Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference
JUPITER, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient, large-scale manufacture of proteins for use in non-pharmaceutical applications including food, nutrition and wellness, as well as animal and human health therapeutics and vaccines, today provided an update on business progress and announced its attendance at the Bioprocess International Conference in Boston, September 23-26, 2024. 
By Dyadic International, Inc. · Via GlobeNewswire · September 23, 2024
DYAI Stock Earnings: Dyadic International Misses EPS, Misses Revenue for Q2 2024investorplace.com
DYAI stock results show that Dyadic International missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 13, 2024
SmallCap Tech/Biotech Stocks July/Aug 2024: ZVSA, DYAI, ZVRA, PRSO, RLMD, VTAK, ENTO, INBS, KAVL
Investors seeking promising opportunities in the biotech and tech sectors should keep an eye on several companies showing potential for significant market turnarounds. Recent upticks in stock prices suggest these companies could be on the cusp of substantial growth. Here's a closer look at some of these emerging players:
Via AB Newswire · July 11, 2024
Roaring Kitty Expands Horizons: Key Stocks to Watch as Influencer Shakes Up Market: CHWY, DYAI, WOOF, VTAK, INBS
The influencer ‘Roaring Kitty’ shook the stock markets with the ‘meme stock’ phenomenon, with GameStop, Inc. (NYSE: GME) becoming his most notable trade. Meme stocks have generated substantial wealth for traders, and it seems Roaring Kitty is now broadening his scope. This feature offers insight into the stock’s worth monitoring in light of Roaring Kitty's latest moves.
Via AB Newswire · July 2, 2024
Dyadic Intl (NASDAQ: DYAI) and Proliant Health Biologicals to Launch $6 Billion Serum Albumin Market Product in 2025
Dyadic International (NASDAQ: DYAI), a global leader in cell culture solutions, announced a strategic partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for the nutrition, diagnostics, and cell culture sectors. Under the agreement, Proliant will provide Dyadic with $1.5 million upfront to develop high-volume, cost-effective cell culture products. The product is set to debut in the first half of 2025 in the $6 billion serum albumin market.
Via AB Newswire · July 1, 2024
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
JUPITER, Fla., June 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for the diagnostic, nutrition and cell culture markets.
By Dyadic International, Inc. · Via GlobeNewswire · June 28, 2024
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Rises in After-Hours Trading Following Major UK Contracts and FDA Progress
On June 25, Intelligent Bio Solutions Inc. (NASDAQ: INBS) trending upwards in after-hours trading. The medical technology company, known for its intelligent, fast, and non-invasive testing solutions, made a significant announcement on June 20. Intelligent Bio Solutions revealed it had successfully signed two major customers in the UK's warehouse and logistics sector over the past three months. These two companies boast a combined workforce of over 15,000 employees across 70 locations.
Via AB Newswire · June 26, 2024
GameStop Raises $2.14 Billion, Meme Stocks Buzz Fuels Gains Watch: GME, PRSO, DYAI, VTAK, AMC
GameStop Corp (NYSE: GME) announced it had raised approximately $2.14 billion through a share sale, positioning the company for potential mergers and acquisitions. The capital infusion opens up various strategic opportunities that GameStop hinted might be forthcoming. Investor confidence surged as stock influencer Keith Gill, known as "Roaring Kitty," indicated he maintained a significant stake in GameStop. A spike in trading of short-dated GameStop options on Wednesday led some market participants to speculate that Gill may have sold some of his recently-disclosed option’s position in the company.
Via AB Newswire · June 13, 2024
Spotlight June 2024: NASDAQ Stocks Under $2 Achieving Major Milestones TELL, DYAI, PRSO, SPEC, GME
In recent days, a surge of interest has spotlighted several key companies, capturing significant attention from investors. This feature delves into a detailed analysis of five standout firms, offering insights that could prove crucial for investors in the near future.
Via AB Newswire · June 11, 2024
Meme Stocks Surge Led by ‘Roaring Kitty’ and Social Media Buzz on Reddit (NYSE: RDDT), GME, DYAI, AMC, PRSO, NVAX
Market activity has picked up, with meme stocks outperforming broader market trends. Interest in these stocks has surged, largely driven by the online influencer known as "Roaring Kitty," who ignited a social media frenzy on Reddit Inc. (NYSE: RDDT) involving GameStop (NYSE: GME) previously. Currently trending stocks on Yahoo Finance include GameStop (NYSE: GME), AMC Entertainment (NYSE: AMC), Dyadic International Inc. (NASDAQ: DYAI), Novavax Inc. (NASDAQ: NVAX), and Peraso Inc. (NASDAQ: PRSO), among others.
Via AB Newswire · June 6, 2024
Dyadic International Inc. (NASDAQ: DYAI) Hits New 52-Week High Amidst Golden Cross, Bullish Swing Patterns and Bird Flu Concerns
Dyadic International Inc. (NASDAQ: DYAI), a biotechnology company specializing in large-scale protein manufacturing for vaccines, therapeutics, and non-pharmaceutical applications like biofuels and next-generation foods, ( read entire press release ) reached a new 52-week high of $2.42 on Thursday, May 30, 2024. This achievement marks a significant 103% increase from its 52-week low of $1.19. The stock's 50-day moving average stands at $1.6631, while the 200-day moving average is $1.6521, culminating in a "Golden Cross" on May 30, 2024. Furthermore, the stock demonstrated a "Jack in the Box" pattern with a Bullish Swing Set-Up on Friday, May 31, 2024. Read the full press release for more details.
Via AB Newswire · June 6, 2024
Peraso Inc. (NASDAQ: PRSO) Announces Paradigm-Shifting mmWave Wi-Fi Advancements with Phased Array Antenna Technology
Peraso Inc. (NASDAQ: PRSO) Utilizing mmWave Wi-Fi, Peraso’s phased array antenna technology enables PSNRD’s latest 60GHz WLAN solution to deliver high-speed, low-latency wireless communication, comparable to wired LAN, over distances extending hundreds of meters. This innovative solution is designed for effortless installation and operation, benefiting from the interference-free and unlicensed use of the 60 GHz band alongside narrow beam directional antenna control. These advancements could represent a significant paradigm shift in the wireless communication industry.
Via AB Newswire · June 6, 2024
Dyadic to Attend Industry Events in June
JUPITER, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well as non-pharmaceutical applications including food, nutrition, and wellness, today announced that its management will be attending the following industry events during June 2024.
By Dyadic International, Inc. · Via GlobeNewswire · May 30, 2024
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns
The coronavirus pandemic, a vivid memory for many, halted the world and reshaped lives. Despite a return to normalcy, the threat of pandemics persists, with the H5N1 avian flu (bird flu) emerging as a potential danger. Health experts caution that a bird flu outbreak could be 100 times more severe than COVID-19.
Via AB Newswire · May 30, 2024
Dyadic (NASDAQ: DYAI) on “The Street Reports Podcast” COO Tackles the Food vs Fuel Debate
Dyadic International Inc. (NASDAQ: DYAI), a leading innovator in biotech, received a significant boost on May 15. On this date, India-based Fermbox Bio, a synthetic biology research and manufacturing firm, announced they launched EN3ZYME, an advanced enzyme combination designed to enhance the efficiency and cost-effectiveness of converting pre-treated agricultural residues into cellulosic and fermentable sugars. On May 14, the company’s COO Joe Hazelton Discussed Expansion into Food and Beverage and the “Future Of Foods” on “The Street Reports Podcast” Listen to The Podcast Now!
Via AB Newswire · May 22, 2024
Top Stocks to Watch: FFIE, PLUG, SPWR, More Inside!
Recently, several companies have disclosed their financial results, attracting investor attention. According to “The Street Experts”, investors should consider monitoring the following three stocks: Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE), originally reported on May 9, 2024 , when the stock price was below $0.10. (See link: https://thestreetreports.com/stocks-on-the-street-under-10%c2%a2-in-focus-ffie-spzi-hnrc-pegy-halb/ ), Plug Power Inc. (NASDAQ: PLUG), and SunPower Corporation (NASDAQ: SPWR) and four additional stocks are discussed in this news article.
Via AB Newswire · May 15, 2024
DYAI Stock Earnings: Dyadic International Reported Results for Q1 2024investorplace.com
Dyadic International just reported results for the first quarter of 2024.
Via InvestorPlace · May 14, 2024
Dyadic to Attend Industry and Investor Events in May
JUPITER, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and to develop and manufacture prophylactic, therapeutic, and nutritional biopharmaceutical products for human and animal health and wellness, today announced that its management will be attending the following industry and investor events during the month of May 2024.
By Dyadic International, Inc. · Via GlobeNewswire · May 8, 2024
Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
JUPITER, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well as in non-pharmaceutical applications including food, nutrition, and wellness, today announced that it will report its financial results for the first quarter 2024 and host a corporate update conference call on Tuesday, May 14, 2024.
By Dyadic International, Inc. · Via GlobeNewswire · April 30, 2024
Discovering Undervalued Stocks in Today’s Market: OCGN, INBS, KAVL, DYAI, VTAK
Ocugen Inc (NASDAQ:OCGN) stock has been moving higher over the past week. This morning, the company announced that Benjamin Bakall, MD, PhD, Director of Clinical Research at Associated Retina Consultants and Clinical Assistant Professor at the University of Arizona, College of Medicine—Phoenix will present data from the OCU400 Phase 1/2 clinical trial at the Retinal Cell and Gene Therapy Innovation Summit being held May 3, 2024 in Seattle, WA.
Via AB Newswire · April 29, 2024